Skip to main content

INDU Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

44th Parliament, 1st Session
Meeting 56
Monday, February 6, 2023, 3:38 p.m. to 5:21 p.m.
In Camera
Presiding
Rick Perkins, Vice-Chair (Conservative)

Library of Parliament
• Sarah Lemelin-Bellerose, Analyst
• Scott McTaggart, Analyst
The committee proceeded to the consideration of matters related to committee business.

It was agreed, — That, pursuant to Standing Order 108(2), the Committee undertake a study of a minimum of two meetings, to examine the situation with Medicago Inc., taking into consideration that it is a Quebec based biotechnology company which received a major investment in federal funds to assist with the development and production of its Health Canada approved made-in-Canada COVID-19 vaccine (Covifenz), that the government of Canada also signed procurement agreements to buy doses of the vaccine and that Medicago Inc. is now going to be closed by its foreign owner, Mitsubishi Chemical Group, and that the Committee invite the following witnesses:

a) the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry;

b) executives and corporate officers of Medicago Inc.;

c)) executives and corporate officers of Mitsubishi Chemical Group and Mitsubishi Tanabe Pharma Corporation.

Pursuant to Standing Order 108(2) and the motion adopted by the committee on Friday, April 8, 2022, the committee resumed its study of small and medium-sized enterprises.

The committee resumed consideration of a draft report.

It was agreed, — That the draft report, as amended, be adopted.

It was agreed, — That the report be entitled: "Small and Medium Enterprises in Canada: Charting a Competitive Future".

It was agreed, — That the Chair, clerk and analysts be authorized to make such grammatical and editorial changes as may be necessary without changing the substance of the report.

It was agreed, — That, pursuant to Standing Order 109, the committee request that the government table a comprehensive response to the report.

It was agreed, — That dissenting or supplementary opinions be submitted electronically, in both official languages, to the clerk of the committee, not later than 5 p.m. on Monday, February 13, 2023.

ORDERED, — That the Chair present the report to the House.

ORDERED, — That the clerk and analysts of the committee, in consultation with the Chair, prepare a news release for publication on the committee’s website and for distribution upon presentation of the report to the House.

At 5:21 p.m., the committee adjourned to the call of the Chair.



Geneviève Desjardins
Committee clerk